Display options
Share it on

Open J Rheumatol Autoimmune Dis. 2012 May;2(2):6-13. doi: 10.4236/ojra.2012.22003.

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

Open journal of rheumatology and autoimmune diseases

Deana D Hoganson, Jun Chen, Richard L Ehman, Jayant A Talwalkar, Clement J Michet, Meng Yin, Cynthia S Crowson, Eric L Matteson

Affiliations

  1. Division of Rheumatology, Mayo Clinic, Rochester.
  2. Department of Radiology, Mayo Clinic, Rochester, MN.
  3. Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
  4. Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
  5. Division of Rheumatology, Mayo Clinic, Rochester ; Department of Health Sciences Research, Mayo Clinic, Rochester, MN.

PMID: 26361561 PMCID: PMC4562680 DOI: 10.4236/ojra.2012.22003

Abstract

INTRODUCTION: Hepatic magnetic resonance elastography (MRE) allows for noninvasive assessment of liver fibrosis. The purpose of this study was to evaluate the usefulness of MRE in detecting and quantifying liver fibrosis in patients with rheumatoid arthritis (RA) who have received methotrexate (MTX).

METHODS: The association between mean liver stiffness value as determined by MRE and variables of interest was determined. The decision for a liver biopsy in participants with an abnormal liver stiffness was made based on clinical judgment.

RESULTS: Sixty-five RA patients were enrolled. Mean liver stiffness value by MRE was abnormal in 7 patients, suggestive of hepatic injury. As a result of findings from the MRE, biopsies were performed in 5 patients and all correlated with elevated liver stiffness values. Elevated mean liver stiffness values were associated with body mass index (BMI) (OR= 1.18 per 1 kg/m

CONCLUSIONS: MRE provides a reliable, non-invasive assessment of liver fibrosis in patients with RA receiving MTX. Patients with RA receiving MTX who have an elevated BMI may be at increased risk for chronic hepatic injury, regardless of MTX cumulative dose or duration of treatment.

Keywords: Hepatic Magnetic Resonance Elastography; Methotrexate; liver fibrosis; rheumatoid arthritis

References

  1. Arthritis Rheum. 1994 Mar;37(3):316-28 - PubMed
  2. Semin Liver Dis. 2008 Nov;28(4):370-9 - PubMed
  3. Joint Bone Spine. 2010 Dec;77(6):588-92 - PubMed
  4. Rheum Dis Clin North Am. 1997 Nov;23 (4):883-915 - PubMed
  5. Ann Rheum Dis. 2005 Feb;64(2):207-11 - PubMed
  6. Gastroenterology. 2008 Jul;135(1):32-40 - PubMed
  7. J Rheumatol. 2004 Sep;31(9):1727-31 - PubMed
  8. Clin Exp Rheumatol. 2005 Jul-Aug;23 (4):517-20 - PubMed
  9. Magn Reson Med. 2008 Aug;60(2):373-9 - PubMed
  10. Ann Rheum Dis. 1991 Jul;50(7):471-6 - PubMed
  11. Gastroenterology. 2008 Jul;135(1):299-302 - PubMed
  12. J Am Acad Dermatol. 1998 Mar;38(3):478-85 - PubMed
  13. Arthritis Rheum. 2000 Feb;43(2):464-5 - PubMed
  14. N Engl J Med. 2002 Apr 18;346(16):1221-31 - PubMed
  15. Radiology. 2006 Aug;240(2):440-8 - PubMed
  16. Am J Med. 1988 Dec;85(6):771-4 - PubMed
  17. J Gastroenterol Hepatol. 2001 Dec;16(12):1395-401 - PubMed
  18. Arthritis Rheum. 1989 Feb;32(2):121-7 - PubMed
  19. J Rheumatol. 2002 Aug;29(8):1590-2 - PubMed
  20. Arthritis Rheum. 1993 Mar;36(3):329-35 - PubMed
  21. Am J Med. 1991 Jun;90(6):711-6 - PubMed
  22. Clin Gastroenterol Hepatol. 2007 Oct;5(10 ):1207-1213.e2 - PubMed
  23. Curr Opin Rheumatol. 2008 Jul;20(4):416-22 - PubMed
  24. Hepatology. 2003 May;37(5):1202-19 - PubMed
  25. J Rheumatol. 1996 Mar;23 (3):459-61 - PubMed
  26. J Rheumatol. 1992 Feb;19(2):229-33 - PubMed
  27. Ann Rheum Dis. 1990 Aug;49(8):591-3 - PubMed

Publication Types

Grant support